IDH2 and central nervous system cancer: Mutations in the genes encoding for isocitrate dehydrogenase (IDH) have been discovered in various cancers such as glioma, acute myeloid leukemia (AML), chondrosarcoma, cholangiocarcinoma, paraganglioma, colon cancer, prostate cancer and lung cancer [2].